Journal article · 2012 · Open access
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Neurodegenerative Diseases, 11(4), 165–181 · Published 10 July 2012 · DOI 10.1159/000337230
In brief
“Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy” is a 2012 journal article by Maj‐Linda B. Selenica and 7 co-authors, published in Neurodegenerative Diseases. OpenAlex counts 10,395 citations as of 15 November 2026, which puts it in the top 1% of works published in 2012 by citations. It is open access: the full text is free to read at PubMed Central.
- Citations
- 10,395
- Most cited in
- 2022 (937)
- Field-weighted impact
- 165.19
- References
- 185
- Authors
- 8
Abstract
BACKGROUND: We aimed to investigate the influence of oligomeric forms of β-amyloid (Aβ) and the influence of the duration of exposure on the development of tau phosphorylation. METHODS: Aβ oligomers were injected intracranially either acutely into 5-month-old rTg4510 mice and tissue was collected 3 days later, or chronically into 3-month-old mice and tissue was collected 2 months later. Several forms of phosphorylated tau (p-tau), GSK3 (glycogen synthase kinase-3) and microglial and astrocyte activation were measured. RESULTS: Acute injections of Aβ oligomers had no effect on p-tau epitopes but did result in elevation of phosphorylated/activated GSK3 (pGSK3). Chronic infusion of Aβ oligomers into the right hippocampus resulted in 3- to 4-fold elevations in several p-tau isoforms with no changes in total tau levels. A significant elevation in pGSK3 accompanied these changes. Microglial staining with CD68 paralleled the increase in tau phosphorylation, however, CD45 staining was unaffected by Aβ. Control experiments revealed that the infusion of Aβ from the minipumps was largely complete by 10 days after implantation. Thus, the elevation in p-tau 2 months after implantation implies that the changes are quite persistent. CONCLUSION: Soluble Aβ(1-42) oligomers have long-lasting effects on tau phosphorylation in the rTg4510 model, possibly due to elevations in GSK3. These data suggest that even brief elevations in Aβ production, may have enduring impact on the risk for tauopathy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Selenica, M. B., Brownlow, M. L., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2012). Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy. Neurodegenerative Diseases, 11(4), 165–181. https://doi.org/10.1159/000337230
MLA 9
Selenica, Maj‐Linda B., et al. “Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy.” Neurodegenerative Diseases, vol. 11, no. 4, 2012, pp. 165–181. https://doi.org/10.1159/000337230.
Chicago
Selenica, Maj‐Linda B., Milene Lara Brownlow, Jeffy P. Jimenez, Daniel C. Lee, Gabriela Pena, Chad A. Dickey, Marcia N. Gordon, and David Morgan. 2012. “Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy.” Neurodegenerative Diseases 11 (4): 165–181. https://doi.org/10.1159/000337230.
Harvard
Selenica, M. B. et al. (2012) ‘Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy’, Neurodegenerative Diseases, 11(4), pp. 165–181. doi:10.1159/000337230.
IEEE
M. B. Selenica et al., “Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy,” Neurodegenerative Diseases, vol. 11, no. 4, pp. 165–181, 2012, doi: 10.1159/000337230.
BibTeX
@article{selenica2012amyloid,
title = {{Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy}},
author = {Selenica, Maj‐Linda B. and Brownlow, Milene Lara and Jimenez, Jeffy P. and Lee, Daniel C. and Pena, Gabriela and Dickey, Chad A. and Gordon, Marcia N. and Morgan, David},
journal = {Neurodegenerative Diseases},
year = {2012},
volume = {11},
number = {4},
pages = {165--181},
doi = {10.1159/000337230},
url = {https://doi.org/10.1159/000337230}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 836 | |
| 2018 | 813 | |
| 2019 | 695 | |
| 2020 | 707 | |
| 2021 | 768 | |
| 2022 | 937 | |
| 2023 | 873 | |
| 2024 | 673 | |
| 2025 | 284 | |
| 2026 | 12 |
Its field-weighted citation impact is 165.19: it has been cited 165.19 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- amyloid-beta oligomers
- tau phosphorylation
- tauopathy
- glycogen synthase kinase-3
- rTg4510 mice
- microglial activation
- astrocyte activation
- hippocampus
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Selenica, M. B., Brownlow, M. L., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2012). Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy. Neurodegenerative Diseases, 11(4), 165–181. https://doi.org/10.1159/000337230
How many times has this paper been cited?
10,395 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at PubMed Central.
Who wrote this paper?
Maj‐Linda B. Selenica, Milene Lara Brownlow, Jeffy P. Jimenez, Daniel C. Lee, Gabriela Pena, Chad A. Dickey, Marcia N. Gordon, David Morgan.
What is the DOI of this paper?
10.1159/000337230. The permanent link is https://doi.org/10.1159/000337230.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.